Hepatitis-C

For Hepatitis-C treatment options in India, please visit our specialized website located at Cure-hepc.com

Hepatitis-C is an infectious viral disease caused by the Hepatitis C Virus which can lead to both acute and chronic infection. It is a blood borne virus and usually does not show its symptoms until much later which is why it is rarely diagnosed in its early stages. More than 130-150 million people are infected with Hepatitis-C globally out of which approximately 500000 people die each year. Currently there are no vaccines for Hepatitis-C so you can only stay away from the disease by taking preventive measures.

There are many ways that someone can get infected with HCV. The most common modes of transmission are:

  • Sharing of Needles.
  • Inadequate Sterilization of Medical Equipment.
  • Screened or un-screened blood transfusion.
  • Unprotected Sex.
  • It can also be transmitted from an infected mother to a baby at the time of birth.

Acute HCV Infection is usually not lethal and 15-45% of the people diagnosed with Hepatitis-C cure themselves as the body’s immune system fights and gets rid of the virus. The remaining people infected with HCV will develop chronic HCV infection which is a life-threatening situation and can also develop into cirrhosis and liver cancer.

About 80% of the people infected with Hepatitis C Virus don’t exhibit any symptoms however for those who do, these are the most common ones:

  • High Fever.
  • Fatigue.
  • Loss of Appetite.
  • Nausea.
  • Vomiting.
  • Abdominal Pains.
  • Dark Yellow Urine.
  • Grey Colored Faeces.
  • Jaundice.

Treatment Options:

Acute Hepatitis C can cure itself however Chronic hepatitis C needs to be treated with drugs. The success rate of these drugs depends on the strain of the Hepatitis C Virus and the type of treatment provided. As of recently, A combination of interferon and ribavirin treatments were used over the course of 48 weeks which had a success rate of about 50% and many side effects.
Latest research has introduced new drugs Gilead Harvoni (Sofosbuvir + Ledipasvir) to be used over a course of 12 weeks having a success rate of 90% with little to no side effects. Though this treatment is currently the best hope of HCV patients, the access to these drugs is very difficult. In U.S and Europe, you can only obtain these drugs when your fibrosis levels are high. If acquired privately, the cost for these drugs goes up to 80000 – 90000 USD for a 12 week regimen.

How Can We Help?

The same drugs that cost a pretty penny in Europe can be obtained for 2000 USD for the entire 12 week course in India. Arimedio’s aim is to make affordable medical treatment available to all HCV patients in a timely manner.

For Hepatitis-C treatment options in India, please visit our specialized website located at Cure-hepc.com

Cities Present

3

Patients Served

200+

Visitors

Get Quote

It’s easy and fast, Start Now!

Call Us
+39-3473257217